Literature DB >> 33639881

Age and multimorbidities as poor prognostic factors for COVID-19 in hemodialysis: a Lebanese national study.

Mabel Aoun1,2, Rabab Khalil3, Walid Mahfoud4, Haytham Fatfat5, Line Bou Khalil6, Rashad Alameddine7, Nabil Afiouni8, Issam Ibrahim9, Mohamad Hassan10, Haytham Zarzour11, Ali Jebai12, Nina Mourad Khalil12, Luay Tawil13, Zeina Mechref14, Zuhair El Imad14, Fadia Chamma15, Ayman Khalil16, Sandy Zeidan17, Balsam El Ghoul17, Georges Dahdah17, Sarah Mouawad18,19, Hiba Azar18,19, Kamal Abou Chahine20, Siba Kallab21, Bashir Moawad21, Ahmad Fawaz22, Joseph Homsi23, Carmen Tabaja24, Maya Delbani24, Rami Kallab25, Hassan Hoballah26, Wahib Haykal27, Najat Fares28, Walid Rahal29, Wael Mroueh30, Mohammed Youssef31, Jamale Rizkallah32, Ziad Sebaaly32, Antoine Dfouni33, Norma Ghosn33, Nagi Nawfal34, Walid Abou Jaoude35, Nadine Bassil35,36, Therese Maroun35,36, Nabil Bassil35,36, Chadia Beaini37, Boutros Haddad28, Elie Moubarak38, Houssam Rabah3, Amer Attieh9, Serge Finianos18,19, Dania Chelala18,19.   

Abstract

BACKGROUND: Hemodialysis patients with COVID-19 have been reported to be at higher risk for death than the general population. Several prognostic factors have been identified in the studies from Asian, European or American countries. This is the first national Lebanese study assessing the factors associated with SARS-CoV-2 mortality in hemodialysis patients.
METHODS: This is an observational study that included all chronic hemodialysis patients in Lebanon who were tested positive for SARS-CoV-2 from 31st March to 1st November 2020. Data on demographics, comorbidities, admission to hospital and outcome were collected retrospectively from the patients' medical records. A binary logistic regression analysis was performed to assess risk factors for mortality.
RESULTS: A total of 231 patients were included. Mean age was 61.46 ± 13.99 years with a sex ratio of 128 males to 103 females. Around half of the patients were diabetics, 79.2% presented with fever. A total of 115 patients were admitted to the hospital, 59% of them within the first day of diagnosis. Hypoxia was the major reason for hospitalization. Death rate was 23.8% after a median duration of 6 (IQR, 2 to 10) days. Adjusted regression analysis showed a higher risk for death among older patients (odds ratio = 1.038; 95% confidence interval: 1.013, 1.065), patients with heart failure (odds ratio = 4.42; 95% confidence interval: 2.06, 9.49), coronary artery disease (odds ratio = 3.27; 95% confidence interval: 1.69, 6.30), multimorbidities (odds ratio = 1.593; 95% confidence interval: 1.247, 2.036), fever (odds ratio = 6.66; 95% confidence interval: 1.94, 27.81), CRP above 100 mg/L (odds ratio = 4.76; 95% confidence interval: 1.48, 15.30), and pneumonia (odds ratio = 19.18; 95% confidence interval: 6.47, 56.83).
CONCLUSIONS: This national study identified older age, coronary artery disease, heart failure, multimorbidities, fever and pneumonia as risk factors for death in patients with COVID-19 on chronic hemodialysis. The death rate was comparable to other countries and estimated at 23.8%.

Entities:  

Keywords:  COVID-19; Hemodialysis; Mortality; Multimorbidities; National study; SARS-CoV-2

Year:  2021        PMID: 33639881     DOI: 10.1186/s12882-021-02270-9

Source DB:  PubMed          Journal:  BMC Nephrol        ISSN: 1471-2369            Impact factor:   2.388


  10 in total

1.  Clinical Characteristics of and Medical Interventions for COVID-19 in Hemodialysis Patients in Wuhan, China.

Authors:  Fei Xiong; Hui Tang; Li Liu; Can Tu; Jian-Bo Tian; Chun-Tao Lei; Jing Liu; Jun-Wu Dong; Wen-Li Chen; Xiao-Hui Wang; Dan Luo; Ming Shi; Xiao-Ping Miao; Chun Zhang
Journal:  J Am Soc Nephrol       Date:  2020-05-08       Impact factor: 10.121

2.  The keys to control a COVID-19 outbreak in a haemodialysis unit.

Authors:  Abraham Rincón; Francesc Moreso; Ana López-Herradón; M Amparo Fernández-Robres; Ignacio Cidraque; Jordi Nin; Orleans Méndez; Marisol López; Carlota Pájaro; Àngels Satorra; Stefano Stuard; Rosa Ramos
Journal:  Clin Kidney J       Date:  2020-07-13

3.  Prevention and management of COVID-19 in hemodialysis centers.

Authors:  Yun Tang; Yi Xin; Fei Deng
Journal:  Am J Manag Care       Date:  2020-08-01       Impact factor: 2.229

4.  Convalescent COVID-19 Patients on Hemodialysis: When Should We End Isolation?

Authors:  Ahmet Murt; Mehmet Rıza Altıparmak
Journal:  Nephron       Date:  2020-05-19       Impact factor: 2.847

5.  Exposure to novel coronavirus in patients on renal replacement therapy during the exponential phase of COVID-19 pandemic: survey of the Italian Society of Nephrology.

Authors:  Giuseppe Quintaliani; Gianpaolo Reboldi; Anteo Di Napoli; Maurizio Nordio; Aurelio Limido; Filippo Aucella; Piergiorgio Messa; Giuliano Brunori
Journal:  J Nephrol       Date:  2020-07-03       Impact factor: 3.902

6.  Recommendations for the prevention, mitigation and containment of the emerging SARS-CoV-2 (COVID-19) pandemic in haemodialysis centres.

Authors:  Carlo Basile; Christian Combe; Francesco Pizzarelli; Adrian Covic; Andrew Davenport; Mehmet Kanbay; Dimitrios Kirmizis; Daniel Schneditz; Frank van der Sande; Sandip Mitra
Journal:  Nephrol Dial Transplant       Date:  2020-05-01       Impact factor: 5.992

7.  COVID-19 and maintenance hemodialysis: a systematic scoping review of practice guidelines.

Authors:  Hossein Akbarialiabad; Shahin Kavousi; Aria Ghahramani; Bahar Bastani; Nasrollah Ghahramani
Journal:  BMC Nephrol       Date:  2020-11-10       Impact factor: 2.388

8.  COVID-19 in patients undergoing chronic kidney replacement therapy and kidney transplant recipients in Scotland: findings and experience from the Scottish renal registry.

Authors:  Samira Bell; Jacqueline Campbell; Jackie McDonald; Martin O'Neill; Chrissie Watters; Katharine Buck; Zoe Cousland; Mark Findlay; Nazir I Lone; Wendy Metcalfe; Shona Methven; Robert Peel; Alison Almond; Vinod Sanu; Elaine Spalding; Peter C Thomson; Patrick B Mark; Jamie P Traynor
Journal:  BMC Nephrol       Date:  2020-10-01       Impact factor: 2.388

9.  Hydroxychloroquine and azithromycin tolerance in haemodialysis patients during COVID-19 infection.

Authors:  Philippe Giaime; Maxime Guenoun; Nathalie Pedinielli; Hervé Narbonne; Jean-Philippe Bergounioux; Caroline Solas; Romain Guilhaumou; Jérôme Sampol; Jacques Ollier; Hélène Sichez; Marianne Serveaux; Flora Brunner; Stanislas Bataille
Journal:  Nephrol Dial Transplant       Date:  2020-08-01       Impact factor: 5.992

10.  Sociodemographic features and mortality of individuals on haemodialysis treatment who test positive for SARS-CoV-2: A UK Renal Registry data analysis.

Authors:  Manuela Savino; Anna Casula; Shalini Santhakumaran; David Pitcher; Esther Wong; Winnie Magadi; Katharine M Evans; Fran Benoy-Deeney; James Griffin; Lucy Plumb; Retha Steenkamp; Dorothea Nitsch; James Medcalf
Journal:  PLoS One       Date:  2020-10-23       Impact factor: 3.240

  10 in total
  3 in total

Review 1.  Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis.

Authors:  Abraham Degarege; Zaeema Naveed; Josiane Kabayundo; David Brett-Major
Journal:  Pathogens       Date:  2022-05-10

2.  Diabetes and Mortality among Patients with Chronic Kidney Disease and COVID-19: A Systematic Review, Meta-analysis, and Meta-regression.

Authors:  Maria R Iryaningrum; Rudi Supriyadi; Sherly Lawrensia; Joshua Henrina; Nanny Natalia M Soetedjo
Journal:  Indian J Nephrol       Date:  2022-05-20

Review 3.  The association between stroke and COVID-19-related mortality: a systematic review and meta-analysis based on adjusted effect estimates.

Authors:  Shuwen Li; Jiahao Ren; Hongjie Hou; Xueya Han; Jie Xu; Guangcai Duan; Yadong Wang; Haiyan Yang
Journal:  Neurol Sci       Date:  2022-03-24       Impact factor: 3.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.